AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AIM ImmunoTech Inc. Director's Dealing 2011

Dec 22, 2011

Director's Dealing

Opens in your device viewer

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2011-12-22

Reporting Person: Bernhardt Charles Thomas III (Chief Financial Officer)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-12-22	Options to buy Common Stock	$0.31	J	100000	Acquired	2021-12-22	Common Stock (100000)	Direct

F1: Options acquired as a result of new employment agreement finalized 12/6/11.